A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.

Also called NCT05552963

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 142 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05552963
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05552963. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-07 (actual); primary completion 2024-12-18 (actual). Results posted on 2026-01-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF)
Acronym
AFIRE
Condition
Refractory Paroxysmal Atrial Fibrillation
Intervention (Device)
Multi-Channel Irreversible Electroporation (IRE) Generator
Intervention (Device)
Multi-Channel Circular IRE Catheter
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05552963
Content hash
f435f6eb53af1977d57cbe3d4ebc909e5099d586ee82baf4186bc0654c10358b